Literature DB >> 21252250

Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions.

Madson Q Almeida1, Michelle Harran, Eirini I Bimpaki, Hui-Pin Hsiao, Anelia Horvath, Chris Cheadle, Tonya Watkins, Maria Nesterova, Constantine A Stratakis.   

Abstract

CONTEXT: Massive macronodular adrenocortical disease or ACTH-independent macronodular adrenal hyperplasia (AIMAH) is a clinically and genetically heterogeneous disorder. OBJECTIVE AND
DESIGN: Whole-genome expression profiling and oligonucleotide array comparative genomic hybridization changes were analyzed in samples of different nodules from the same patients with AIMAH. Quantitative RT-PCR and staining were employed to validate the mRNA array data.
RESULTS: Chromosomal gains were more frequent in larger nodules when compared with smaller nodules from the same patients. Among the 50 most overexpressed genes, 50% had a chromosomal locus that was amplified in the comparative genomic hybridization data. Although the list of most over- and underexpressed genes was similar between the nodules of different size, the gene set enrichment analysis identified different pathways associated with AIMAH that corresponded to the size; the smaller nodules were mainly enriched for metabolic pathways, whereas p53 signaling and cancer genes were enriched in larger nodules. Confirmatory studies demonstrated that BCL2, E2F1, EGF, c-KIT, MYB, PRKCA, and CTNNB1 were overexpressed in the larger nodules at messenger and/or protein levels. Chromosomal enrichment analysis showed that chromosomes 20q13 and 14q23 might be involved in progression of AIMAH from smaller to larger tumors.
CONCLUSION: Integrated transcriptomic and genomic data for AIMAH provides supporting evidence to the hypothesis that larger adrenal lesions, in the context of this chronic, polyclonal hyperplasia, accumulate an increased number of genomic and, subsequently, transcript abnormalities. The latter shows that the disease appears to start with mainly tissue metabolic derangements, as suggested by the study of the smaller nodules, but larger lesions showed aberrant expression of oncogenic pathways.

Entities:  

Mesh:

Year:  2011        PMID: 21252250      PMCID: PMC3070257          DOI: 10.1210/jc.2010-2420

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  47 in total

1.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

2.  A role for pericytes as microenvironmental regulators of human skin tissue regeneration.

Authors:  Sophie Paquet-Fifield; Holger Schlüter; Amy Li; Tara Aitken; Pradnya Gangatirkar; Daniel Blashki; Rachel Koelmeyer; Normand Pouliot; Manuela Palatsides; Sarah Ellis; Nathalie Brouard; Andrew Zannettino; Nick Saunders; Natalie Thompson; Jason Li; Pritinder Kaur
Journal:  J Clin Invest       Date:  2009-08-03       Impact factor: 14.808

3.  Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.

Authors:  Irina Nazarenko; Sanyukta Rana; Alexandra Baumann; Jessica McAlear; Andrea Hellwig; Michael Trendelenburg; Günter Lochnit; Klaus T Preissner; Margot Zöller
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

4.  Comparative genomic hybridization analysis of adrenocortical tumors.

Authors:  Stan Sidhu; Deborah J Marsh; George Theodosopoulos; Jeanette Philips; Christopher P Bambach; Peter Campbell; Christopher J Magarey; Colin F J Russell; Klaus-Martin Schulte; Hans-Dietrich Röher; Leigh Delbridge; Bruce G Robinson
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

5.  MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling.

Authors:  Dimitrios Iliopoulos; Eirini I Bimpaki; Maria Nesterova; Constantine A Stratakis
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

6.  Somatic mutations affect key pathways in lung adenocarcinoma.

Authors:  Li Ding; Gad Getz; David A Wheeler; Elaine R Mardis; Michael D McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M Muzny; Margaret B Morgan; Lucinda Fulton; Robert S Fulton; Qunyuan Zhang; Michael C Wendl; Michael S Lawrence; David E Larson; Ken Chen; David J Dooling; Aniko Sabo; Alicia C Hawes; Hua Shen; Shalini N Jhangiani; Lora R Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E Scherer; Kerstin Clerc; Ginger A Metcalf; Brian Ng; Aleksandar Milosavljevic; Manuel L Gonzalez-Garay; John R Osborne; Rick Meyer; Xiaoqi Shi; Yuzhu Tang; Daniel C Koboldt; Ling Lin; Rachel Abbott; Tracie L Miner; Craig Pohl; Ginger Fewell; Carrie Haipek; Heather Schmidt; Brian H Dunford-Shore; Aldi Kraja; Seth D Crosby; Christopher S Sawyer; Tammi Vickery; Sacha Sander; Jody Robinson; Wendy Winckler; Jennifer Baldwin; Lucian R Chirieac; Amit Dutt; Tim Fennell; Megan Hanna; Bruce E Johnson; Robert C Onofrio; Roman K Thomas; Giovanni Tonon; Barbara A Weir; Xiaojun Zhao; Liuda Ziaugra; Michael C Zody; Thomas Giordano; Mark B Orringer; Jack A Roth; Margaret R Spitz; Ignacio I Wistuba; Bradley Ozenberger; Peter J Good; Andrew C Chang; David G Beer; Mark A Watson; Marc Ladanyi; Stephen Broderick; Akihiko Yoshizawa; William D Travis; William Pao; Michael A Province; George M Weinstock; Harold E Varmus; Stacey B Gabriel; Eric S Lander; Richard A Gibbs; Matthew Meyerson; Richard K Wilson
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

7.  Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds.

Authors:  Lucia Gagliardi; Cheri Hotu; Graeme Casey; Wilton J Braund; King-Hwa Ling; Thomas Dodd; James Manavis; Peter G Devitt; Richard Cutfield; Zbigniew Rudzki; Hamish S Scott; David J Torpy
Journal:  Clin Endocrinol (Oxf)       Date:  2008-11-05       Impact factor: 3.478

8.  Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.

Authors:  Hui-Pin Hsiao; Lawrence S Kirschner; Isabelle Bourdeau; Margaret F Keil; Sosipatros A Boikos; Somya Verma; Audrey J Robinson-White; Maria Nesterova; André Lacroix; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

Review 9.  ACTH-independent macronodular adrenal hyperplasia.

Authors:  André Lacroix
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-04       Impact factor: 4.690

10.  An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.

Authors:  D Chitale; Y Gong; B S Taylor; S Broderick; C Brennan; R Somwar; B Golas; L Wang; N Motoi; J Szoke; J M Reinersman; J Major; C Sander; V E Seshan; M F Zakowski; V Rusch; W Pao; W Gerald; M Ladanyi
Journal:  Oncogene       Date:  2009-06-15       Impact factor: 9.867

View more
  17 in total

1.  Adrenocorticotropic hormone independent macronodular adrenal hyperplasia.

Authors:  Peter Mwamure; Kingsley Nirmalaraj; Louise Wolmarans
Journal:  BMJ Case Rep       Date:  2011-07-28

2.  Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.

Authors:  Anne-Lise Lecoq; Constantine A Stratakis; Say Viengchareun; Ronan Chaligné; Lucie Tosca; Vianney Deméocq; Mirella Hage; Annabel Berthon; Fabio R Faucz; Patrick Hanna; Hadrien-Gaël Boyer; Nicolas Servant; Sylvie Salenave; Gérard Tachdjian; Clovis Adam; Vanessa Benhamo; Eric Clauser; Anne Guiochon-Mantel; Jacques Young; Marc Lombès; Isabelle Bourdeau; Dominique Maiter; Antoine Tabarin; Jérôme Bertherat; Hervé Lefebvre; Wouter de Herder; Estelle Louiset; André Lacroix; Philippe Chanson; Jérôme Bouligand; Peter Kamenický
Journal:  JCI Insight       Date:  2017-09-21

3.  The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia.

Authors:  Ricardo Correa; Mihail Zilbermint; Annabel Berthon; Stephanie Espiard; Maria Batsis; Georgios Z Papadakis; Paraskevi Xekouki; Maya B Lodish; Jerome Bertherat; Fabio R Faucz; Constantine A Stratakis
Journal:  Eur J Endocrinol       Date:  2015-07-10       Impact factor: 6.664

4.  Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.

Authors:  Madson Q Almeida; Monalisa F Azevedo; Paraskevi Xekouki; Eirini I Bimpaki; Anelia Horvath; Michael T Collins; Lefkothea P Karaviti; George S Jeha; Nisan Bhattacharyya; Chris Cheadle; Tonya Watkins; Isabelle Bourdeau; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2012-01-18       Impact factor: 5.958

5.  c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.

Authors:  Kiran Nadella; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-10       Impact factor: 5.678

Review 6.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

Review 7.  Genetics and epigenetics of adrenocortical tumors.

Authors:  Antonio M Lerario; Andreas Moraitis; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2013-11-09       Impact factor: 4.102

8.  ZNF764 haploinsufficiency may explain partial glucocorticoid, androgen, and thyroid hormone resistance associated with 16p11.2 microdeletion.

Authors:  Tomoshige Kino; Maria G Pavlatou; Andreas G Moraitis; Robin L Nemery; Margarita Raygada; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2012-05-10       Impact factor: 5.958

9.  Insulin-like growth factor 2 (IGF2) expression in adrenocortical disease due to PRKAR1A mutations compared to other benign adrenal tumors.

Authors:  Kiran S Nadella; Annabel Berthon; Madson Q Almeida; Isaac Levy; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocrine       Date:  2021-01-09       Impact factor: 3.633

10.  The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.

Authors:  Deniz M Özata; Stefano Caramuta; David Velázquez-Fernández; Pinar Akçakaya; Hong Xie; Anders Höög; Jan Zedenius; Martin Bäckdahl; Catharina Larsson; Weng-Onn Lui
Journal:  Endocr Relat Cancer       Date:  2011-10-27       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.